ClinicalTrials.gg
RecruitingNCT05273879Updated Dec 18, 2025

Necessity of Fusion Following Decompression Surgery in Patients With Single-level Lumbar Stenosis

An interventional study of decompression and fusion in Lumbar Spinal Stenosis, Spinal Stenosis and Spinal Fusion, sponsored by Sklifosovsky Institute of Emergency Care. Recruiting at 2 sites in Russia. Open to participants aged 45 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-12-18.

Sponsored by Sklifosovsky Institute of Emergency Care · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2022; still recruiting 4 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
45 Years to 75 Years
Sex
All
01

Study summary

Long-term clinical results of two methods of surgical treatment (spinal decompression with or without fusion) in patients with single-level lumbar stenosis will be compared. A clear framework for surgical treatment methods and standardized postoperative rehabilitation treatment will be set to obtain the maximum homogeneity of the patient groups.

This trial should provide the first level of evidence for the need for spinal fusion in patients with single-level lumbar stenosis, subject to the high homogeneous comparison groups. Additional results will allow comparing the economic aspects of different surgical treatments for 2 years after surgery.

Read the detailed description

The necessity of spinal segment fusion after decompression is one of the most controversial and unresolved issues in single-level lumbar spinal stenosis surgery. To date, only one trial carried out 15 years ago focused on this problem. The key purpose of the current trial is to compare the long-term clinical results of the two surgical methods (decompression vs. decompression and fusion) in patients with single-level lumbar stenosis.

This study is focused on the non-inferior clinical results of decompression compared with the standard fusion procedure. In the decompression group, the spinous process, the interspinous and supraspinous ligaments, part of the facet joints, and corresponding parts of the vertebral arch are to be preserved intact. In the fusion group, decompression is to be supplemented with transforaminal interbody fusion. Participants meeting the inclusion criteria will be randomly divided into two equal groups (1:1), depending on the surgical method. The final analysis will include 86 patients (43 per group). The primary endpoint is Oswestry Disability Index dynamics at the end of the 24-month follow-up compared to the baseline level. Secondary outcomes included those estimated using the SF-36 scale, EQ-5D-5L, and psychological scales. Additional parameters will include sagittal balance of the spine, fusion results, total cost of surgery, and hospital stay followed by two-year treatment. Follow-up examinations will be performed at 3, 6, 12, and 24 months Authors suggest that this study will improve the evidence for application of various surgical techniques for lumbar spine stenosis surgery and verify the existing protocol for surgical management.

02

Conditions studied

  • Lumbar Spinal Stenosis
  • Spinal Stenosis
  • Spinal Fusion

Keywords

  • lumbar spine
  • lumbar fusion
  • laminotomy
  • decompression without fusion
  • lumbar stenosis
03

In context

Spinal Stenosis

458 studies on the registry are indexed under Spinal Stenosis; 105 are open to participants now.

This study's planned enrollment of 86 is close to the median of 80 across 281 interventional studies indexed under Spinal Stenosis.

Browse Spinal Stenosis studies →

Lead sponsor

Sklifosovsky Institute of Emergency Care is the lead sponsor of 13 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age of patients from 45 to 75 years;
  • stenosis C or D according to Shizas et al. according to MRI at the level of L2-L3, L3-L4, L4-L5 or L5-S1;
  • clinical manifestations of lumbar stenosis (neurogenic claudication syndrome and/or radiculopathy);
  • lack of effect from conservative therapy within 3 months;
  • to take part in the study.

Exclusion criteria

Exclusion Criteria:

  • spondylolisthesis more than 3 mm;
  • spinal instability according to functional radiography;
  • sagittal imbalance (type 4 according to C. Barrey);
  • bone density of the vertebrae at the level of the operation is less than 100 HU;
  • spinal stenosis at 2 or more levels;
  • previously performed surgeries on the spine;
  • risk of anesthesia 4 or 5 according to ASA;
  • inability to take part in control examinations within 2 years after the operation;
  • participation in other clinical trials related to surgical or conservative treatment of diseases of the spine.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
86 participants (estimated)

Study arms

  • Other
    decompression group

    minimally invasive decompression without fusion

    Procedure: decompression

  • Other
    fusion group

    minimally invasive decompression with trans-foraminal interbody fusion

    Procedure: fusion

Interventions

  • Proceduredecompression

    laminotomy of the corresponding adjacent vertebrae, partial flavectomy and medial facetectomy are planned to be performed unilaterally. Depending on the surgeon's personal preferences, the following two options are available: 1) equivalent decompression procedure contralaterally and 2) crossover contralateral decompression. Irrespective of the selected option, the spinous process, the interspinous and supraspinous ligaments, part of the facet joints, and the corresponding part of the vertebral arch must be preserved intact in all participants.

  • Procedurefusion

    First, decompression is performed according to one of the above methods. Next, trans-foraminal interbody fusion with a cage (TLIF) and fixation with pedicle screws are performed.

06

What researchers measure

Primary outcomes

  1. Oswestry Disability Index

    The questionnaire includes 10 sections containing 6 statements each. Depending on the answer, a score is assigned (from 0 to 5). The maximum number of points is 50. After that, the points are converted into percentages (from 0 to 100%).

    Time frame: 24 months

Secondary outcomes

  1. SF-36 v.1 scale (standard form)

    The questionnaire contains 36 questions, grouped into 8 scales that assess physical functioning, role-playing, bodily pain, general health, vitality, social functioning, emotional state, and mental health. For each of them, the maximum score is 100 points.

    Time frame: 24 months

  2. EQ-5D-5L

    The questionnaire contains 5 sections (mobility, self-care, usual activities, pain, anxiety) of three statements and the EQ-VAS visual analog pain scale. The results can be converted into a single numerical value (index) adjusted for the patient's region of residence

    Time frame: 24 months

  3. Won-Korff Chronic Pain Syndrome Assessment Scale

    allows evaluating the severity of pain and its impact on life in points. Grade 0 corresponds to the absence of pain, and grade IV to the maximum limitation of life because of severe pain.

    Time frame: 24 months

  4. Pain Catastrophizing Scale

    makes it possible to assess completely the psychological aspects of pain perception, in particular the exaggerated negative perception of painful stimuli. The questionnaire contains 13 questions, each of which is evaluated in points (0 points, no symptom, 4, the patient experiences these feelings all the time).

    Time frame: 24 months

  5. Chronic Pain Coping Inventory

    allow one of eight scales to classify a patient's preferred strategy for coping with chronic pain.

    Time frame: 24 months

  6. scale of the American Society of Anesthesiologists ASA

    This classification distinguishes 5 classes of physical status depending on the presence of concomitant diseases (Class I, healthy patient, Class V, dying).

    Time frame: baseline

  7. The cost of the treatment

    The cost of hospitalization of the patient, including the performance of surgical intervention, as well as the period of the patient's incapacity for work because of spinal disease, will also be calculated. Also, within 2 years after the intervention, the cost of subsequent treatment in rehabilitation centers and other hospitals for complications of the operation or other manifestations of degenerative-dystrophic changes in the lumbar spine will be considered.

    Time frame: 24 months

  8. quality of fusion

    according to CT data, the quality of fusion using the Tan criteria will be graded into one of four grades of fusion-grade I (complete fusion) to grade IV (bipolar pseudarthrosis)

    Time frame: 24 months

  9. pelvic tilt (PT)

    a parameter defined as the angle created by a line running from the sacral endplate midpoint to the center of the bifemoral heads and the vertical axis. Will be evaluated on X-ray.

    Time frame: 24 months

  10. pelvic incidence (PI)

    the angle between the line perpendicular to the sacral endplate at its midpoint and a line connecting this point to the axis of the femoral head. Will be evaluated on X-ray.

    Time frame: 24 months

  11. sacral slope (SS)

    the angle between the tangent line to the superior endplate of S1 and the horizontal plane. Will be evaluated on X-ray.

    Time frame: 24 months

  12. al axis displacement (SVA)

    a horizontal distance between a plumb line dropped from the center of the C7 body and the posterior-superior corner of the S1 body. Will be evaluated on X-ray.

    Time frame: 24 months

07

Study locations

2 of 2 sites recruiting
  • Pirogov National Medical and Surgical Center
    Moscow, Moscow 105203, Russia
    Recruiting
    • Valeriy Lebedev, MD, PhD · Contacthorizont_vbl@mail.ru · +79264922952
    • Dmitriy Epifanov · Sub investigator
  • Sklifosovsky Research Institute for Emergency Medicine
    Moscow, Moscow 107045, Russia
    Recruiting
    • Ivan Lvov, MD, PhD · Contactdr.speleolog@gmail.com · +79265760074
    • Anton Kordonskiy, MD, PhD · Contactakord.neuro@mail.ru · +79265724547
    • Andrey Grin, MD, PhD · Principal investigator
    • Ivan Lvov, MD, PhD · Principal investigator
    • Anton Kordonskiy, MD, PhD · Principal investigator
08

References and documents

Publications

  • Grin A, Lvov I, Talypov A, Smirnov V, Kordonskiy A, Lebedev V, Zuev A, Senko I, Pogonchenkova I, Krylov V. Necessity of fusion following decompression surgery in patients with single-level lumbar stenosis: study protocol for an open-label multicentre non-inferiority randomized controlled clinical trial. Trials. 2023 Jul 10;24(1):451. doi: 10.1186/s13063-023-07486-8. PubMed 37430281 ↗

Individual participant data

Plan to share: Yes — Data are available upon reasonable request in Sklifosovsky Research Institute for Emergency Medicine

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: Study protocol will be available after march 2022. An interim analysis will be conducted when follow-up data is available at 12 months for at least 20 patients in each cohort. Final analysis will be presented after december 2026

Access criteria: the approval of institutional review board

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05273879
Lead sponsor
Sklifosovsky Institute of Emergency Care
Collaborators
Pirogov National Medical Surgical Center, Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine
Responsible party
Ivan Lvov, MD, PhD (Senior fellow, Sklifosovsky Institute of Emergency Care) — Principal investigator
First posted
Mar 10, 2022
Start date
Apr 1, 2022
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Dec 18, 2025

Study contacts

Ivan Lvov, MD, PhD
Contact
dr.speleolog@gmail.com
+79265760074
Anton Kordonskiy, MD, PhD
Contact
akord.neuro@mail.ru
+79265724547
Andrey Grin, MD, PhD
study chair · Sklifosovsky Research Institute for Emergency Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion